A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.

OBJECTIVE: To compare intravaginal 5-fluorouracil (5-FU) and placebo for the treatment of cervical and/or vaginal human papillomavirus (HPV). METHODS: A randomized, placebo-controlled trial was performed. Women with HPV detected visually or by Papanicolaou (Pap) test and confirmed by colposcopic bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmes, M M, Weaver, S H, Vermillion, S T
Formato: Texto
Lenguaje:English
Publicado: 1999
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784744/
https://www.ncbi.nlm.nih.gov/pubmed/10449266
http://dx.doi.org/10.1002/(SICI)1098-0997(1999)7:4<186::AID-IDOG4>3.0.CO;2-Z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784744/
https://www.ncbi.nlm.nih.gov/pubmed/10449266
http://dx.doi.org/10.1002/(SICI)1098-0997(1999)7:4<186::AID-IDOG4>3.0.CO;2-Z

Ejemplares similares